Alzheimer's Screening Package
Combining advanced blood-based biomarker analysis with digital cognitive testing, this comprehensive assessment offers a broader perspective on brain health and Alzheimer’s disease risk. By evaluating biological indicators associated with Alzheimer’s alongside objective measures of cognitive performance, it brings together two complementary approaches to support a more informed understanding of an individual's cognitive health. Combined with expert clinical interpretation, the assessment supports informed decision-making and appropriate next steps.
For whom
Individuals experiencing memory concerns or cognitive changes, those with a family history or other risk factors for Alzheimer’s disease, and individuals seeking a proactive, comprehensive assessment of their brain health.
What
A combined assessment incorporating blood-based biomarkers associated with Alzheimer’s disease and digital cognitive testing to evaluate key aspects of cognitive function, including memory, attention, learning and executive function.
How
Through a simple blood sample to analyse relevant Alzheimer’s-associated biomarkers, alongside computerised cognitive assessments using CANTAB Insight and/or CANTAB One. The findings are considered together, with expert clinical interpretation providing context for the results and supporting personalised recommendations where appropriate.
Why
To bring together biological and cognitive insights for a more comprehensive understanding of brain health, help inform discussions around Alzheimer’s disease risk and cognitive changes, and support appropriate clinical follow-up and next steps.
